As the bulls reassert their power, leading stocks like SanDisk, Coinbase, and Moderna are setting up

Benzinga examined the prospects for many investors’ favorite stocks over the last week — here’s a lo

Axsome Therapeutics is seeing significant revenue growth as its central nervous system portfolio gai

This whale alert can help traders discover the next big trading opportunities. Whales are entities w

The Fed hiked to 4%, Generac jumped 40% on Amazon warrants, and more

Major U.S. indices closed higher on Thursday, with the Dow Jones Industrial Average rising 0.61% to

Wall Street snapped a two-day losing streak Thursday as oil retreated from its geopolitical spike an

Moderna Inc. (NASDAQ:MRNA) shares are popping Thursday, extending a month-long rally that began with

Moderna Inc. (NASDAQ: MRNA) shares are popping Thursday, extending a month-long rally that began wit

Moderna, Inc‘s (NASDAQ:MRNA) biggest problem is no longer proving that its mRNA technology can work

Moderna stock has more than doubled after its cancer-vaccine breakthrough. Now investors face the ha

U.S. stocks rose; Vicor jumped 13.5% on a new license, while Generac surged 19.6% on an Amazon deal.

Cancer vaccine momentum is doing the work for Moderna (NASDAQ:MRNA | MRNA Price Prediction) once aga

Forgent reports bumper quarter, Nvidia joins the AI safety debate, and more

Shares of Moderna MRNA have staged a remarkable comeback this year as investors increasingly warm to

In the closing of the recent trading day, Moderna (MRNA) stood at $146.69, denoting a +1.89% move fr

Moderna built an artificial intelligence that reads a patient's tumor and decides what that patient'

Moderna, Inc. (MRNA) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript

Moderna's recent success in a phase 3 clinical trial for its personalized cancer vaccine was a break

Moderna NASDAQ: MRNA President Stephen Hoge said the company's recently announced positive Phase III

AI Drug Discovery Market Projected to Reach $13.8 Billion by 2033PR NewswireAUSTIN, Texas, Sept. 14,

Income seekers can't go wrong with these companies.

Moderna had too much volatility as a swing trade. But ARK Genomics Revolution ETF allowed us to mana

Moderna (NASDAQ:MRNA | MRNA Price Prediction) stock is up 8% to $147.37 in Friday morning trading, a

U.S. stocks rose; Frequency Electronics surged 30.7% after beating Q1 estimates, while ACV Auctions

Amundi lowered its stake in Moderna, Inc. (NASDAQ: MRNA) by 1.8% during the undefined quarter, accor

Retail investors often monitor the trading activity of members of Congress. Investors may want to pa

A congresswoman recently bought stocks connected to Warren Buffett and Elon Musk.

Amgen delivers strong profitability and a diverse portfolio of established chronic disease treatment

If AI and robotics suddenly feel like they are moving faster, August gave investors plenty of eviden

This whale alert can help traders discover the next big trading opportunities. Whales are entities w

Analysts downgraded Ultragenyx, Moderna and Sonoco; targets fell for RARE and SON but rose for MRNA.

Analysts revised price targets for Ultragenyx, UiPath, Netskope, Snowflake, Magnite, Broadcom, Crowd

Rothschild & Co analyst Simon Baker downgrades Moderna (NASDAQ:MRNA) from Neutral to Sell and

This whale alert can help traders discover the next big trading opportunities. Whales are entities w

Shares of Moderna Inc (NASDAQ: MRNA) are trading lower Wednesday morning, taking a breather followin

The 10-year Treasury yield hit a 19-month high and crude jumped above $88 as traders lifted Fed rate

Moderna’s cancer vaccine breakthrough puts biotech, mRNA and genomics ETFs in focus. Here are the fu

Moderna Inc (NASDAQ: MRNA) shares are trading higher Tuesday morning. Here's what investors need

https://www.who.int/news/item/28-08-2026-second-meeting-of-the-ihr-emergency-committee-on-the-epidem

Wall Street analysts upgraded Moderna Inc and Evolution Petroleum Corp, and raised Enbridge's pr

Shares of Moderna are trading lower Friday morning after the company announced official terms for a

Argus Research analyst John Eade upgrades Moderna (NASDAQ:MRNA) from Hold to Buy and announces $1

FDA approves updated COVID-19 vaccines for 2026-'27 season, targeting XFG variant. Limited eligi

Dolly Parton left a lasting legacy across music, TV, film and entertainment. The singer also leaves

This whale alert can help traders discover the next big trading opportunities. Whales are entities w

Nvidia surged 9% and cybersecurity names exploded higher, yet 10 of 11 S&P 500 sectors fell as y

Moderna announces a $2 billion convertible senior note offering to fund its oncology business growth

Nasdaq 100 falls 0.6% as traders wait on Nvidia and hot July PCE revives September rate-hike bets. E

Moderna shares are trading lower Wednesday morning, pausing after a 150% surge on landmark clinical